Table 1. CEC positivity by diagnosis.
All | 171 | 91 (53.2%) | 24 (14.0%) | 56 (32.7%) |
PDAC | 108 | 53 (49.1%) | 19 (17.6%) | 36 (33.3%) |
Cholangiocarcinoma | 8 | 4 (50.0%) | 0 (0%) | 4 (50.0%) |
Ampullary CA | 7 | 4 (57.1%) | 0 (0%) | 3 (42.9%) |
NET | 9 | 6 (66.7%) | 2 (22.2%) | 1 (11.1%) |
SPN | 3 | 2 (66.7%) | 0 (0%) | 1 (33.3%) |
Acinar cell CA | 1 | 0 (0%) | 0 (0%) | 1 (100.0%) |
IPMN | 16 | 12 (75.0%) | 0 (0%) | 4 (25.0%) |
MCN | 1 | 1 (100.0%) | 0 (0%) | 0 (0%) |
Ampullary adenoma | 3 | 1 (33.3%) | 0 (0%) | 2 (66.7%) |
Serous cystadenoma | 2 | 2 (100.0%) | 0 (0%) | 0 (0%) |
Splenic epidermoid cyst | 1 | 0 (0%) | 0 (0%) | 1 (100.0%) |
Pancreatitis | 12 | 6 (50.0%) | 3 (25.0%) | 3 (25.0%) |
CEC: Circulating epithelioid cells. +: Positive. Susp: suspicious. -: Negative. PDAC: Pancreatic ductal adenocarcinoma. CA: Carcinoma. NET: Neuroendocrine tumor. SPN: Solid-pseudopapillary neoplasm. IPMN: Intraductal papillary mucinous neoplasm. MCN: Mucinous cystic neoplasm. SCA: Serous cystadenoma